Nurix Therapeutics, Inc. (NRIX)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
39
$1.26B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $212.77M |
| FMR LLC | Aug 13, 2026 | $133.07M |
| T. Rowe Price Associates, Inc. | Aug 14, 2026 | $131.89M |
| MORGAN STANLEY | Aug 13, 2026 | $115.54M |
| STATE STREET CORPORATION | Aug 7, 2026 | $113.47M |
NRIX's filings are public. The insight is one click away.
Scrutar's AI reads every NRIX filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze NRIX filingsNo credit cardAI reports included on the free plan
Never miss a NRIX filing.
Get an email when NRIX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Sep 15, 2026Source: SEC EDGAR.